Randomised Controlled TrialiVNSn = 84

Effect of Vagal Nerve Blockade on Moderate Obesity with an Obesity-Related Comorbid Condition: the ReCharge Study

Morton JM, Shah SN, Wolfe BM, Apovian CM, Miller CJ, Tweden KS, Billington CJ, Shikora SA

Obesity Surgery · 2016

Key finding

In the prespecified subgroup of 84 patients with moderate obesity (BMI 35-40), vBloc therapy produced significantly greater excess weight loss than sham at 12 months with a favorable safety profile.

Condition
Obesity
Stimulation
iVNS
Evidence tier
Randomised Controlled Trial
Participants
84
View on DOI

Cite this study

Morton, J. M., Shah, S. N., Wolfe, B. M., Apovian, C. M., Miller, C. J., Tweden, K. S., Billington, C. J., & Shikora, S. A. (2016). Effect of Vagal Nerve Blockade on Moderate Obesity with an Obesity-Related Comorbid Condition: the ReCharge Study. Obesity Surgery, 26(5), 983-989. https://doi.org/10.1007/s11695-016-2143-y

Related studies in Obesity

Summary by Vagus Research. Always consult the primary source for the authoritative record.

Stay Current with the Research

Join researchers and practitioners exploring the science of vagus nerve stimulation. Receive curated research summaries and evidence updates.

No spam. Unsubscribe at any time. We respect your privacy.